NV-52: A novel thromboxane synthase inhibitor for the treatment of inflammatory bowel disease

Laurence Guy Howes, Michael John James, Timothy Florin, Catherine Walker, Michael C James

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalExpert opinion on investigational drugs
Volume16
StatePublished - Jan 1 2007

Cite this